Biological
COVID-19 convalescent plasma clinical trials
- studies test it
- 29
- open now
- 0
- in phase 3
- 7
- first study started
- 2020
How studies write it
Studies that test it under each name
Studies by the year they started
29 studies that test it; most in 2020 (26)
| Year | Studies |
|---|---|
| 2020 | 26 |
| 2021 | 3 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 6
- Phase 1
- 5
- Phase 2
- 16
- Phase 3
- 7
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
- COVID-19
- 27
Who runs them
Industry 1 · Other 28
Joakim Dillner (3) · Johns Hopkins University (2) · University of Pennsylvania (2) · The Methodist Hospital Research Institute (1) · Max O'Donnell (1) · Vinmec Research Institute of Stem Cell and Gene Technology (1) · Institute for Transfusion Medicine of RNM (1) · Medical College of Wisconsin (1)
Studies
Open first, then newest update. How each study uses COVID-19 convalescent plasma is read from its arms, and is right about nine times in ten.
Testing it · 29
- Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)CompletedPhase 1The Methodist Hospital Research InstituteNCT04554992Written as COVID 19 Convalescent Plasma
- Plasma Therapy of COVID-19 in Severely Ill PatientsCompletedPhase 2Max O'DonnellNCT04359810Written as Convalescent Plasma (anti-SARS-CoV-2 plasma)
- Convalescent Plasma for Early Treatment of COVID-19TerminatedPhase 2Andrew EisenbergerNCT04390503Written as Convalescent Plasma (anti-SARS-CoV-2 plasma)
- Convalescent Plasma for COVID-19 PatientsCompletedEarly Phase 1Vinmec Research Institute of Stem Cell and Gene TechnologyNCT04516954Written as Convalescent COVID 19 Plasma
- Efficacy and Safety of COVID-19 Convalescent PlasmaCompletedNot applicableInstitute for Transfusion Medicine of RNMNCT04397523Written as anti-SARS-CoV-2 convalescent plasma
- Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized PatientsCompletedPhase 2Medical College of WisconsinNCT04354831Written as anti-SARS-CoV-2 convalescent plasma
- COVID-19 Convalescent PlasmaCompletedEarly Phase 1University of ChicagoNCT04340050Written as anti-SARS-CoV-2 convalescent plasma
- CoVID-19 Plasma in Treatment of COVID-19 PatientsCompletedEarly Phase 1The Christ HospitalNCT04355897Written as Convalescent COVID 19 Plasma
- Convalescent Plasma to Limit SARS-CoV-2 Associated ComplicationsCompletedPhase 2Johns Hopkins UniversityNCT04373460Written as SARS-CoV-2 convalescent plasma
- Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19CompletedEarly Phase 1Hospital Regional Dr. Rafael EstévezNCT05595538Written as Multiple doses of anti-SARS-CoV-2 Convalescent Plasma
- Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized PatientsCompletedPhase 2Priscilla Hsue, MDNCT04421404Written as COVID-19 Convalescent Plasma (CCP)
- VA CoronavirUs Research and Efficacy Studies-1TerminatedPhase 3VA Office of Research and DevelopmentNCT04539275Written as Convalescent Plasma
- Convalescent Plasma as Potential Therapy for Severe COVID-19 PneumoniaCompletedPhase 3Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoNCT04535063Written as COVID19 convalescent plasma infusion
- Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19TerminatedPhase 2/3University of the PhilippinesNCT04567173Written as Anti-SARS-CoV-2 convalescent plasma
- Convalescent Plasma to Stem Coronavirus (CSSC-001)CompletedPhase 2Johns Hopkins UniversityNCT04323800Written as Anti- SARS-CoV-2 Plasma
- COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.CompletedPhase 1University of PennsylvaniaNCT04397757Written as COVID-19 Convalescent Plasma
- COVID-19 Convalescent Plasma for Mechanically Ventilated PopulationCompletedPhase 1University of PennsylvaniaNCT04388527Written as COVID-19 Convalescent Plasma
- ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)TerminatedPhase 2William Beaumont HospitalsNCT04432272Written as COVID-19 convalescent plasma
- Convalescent Plasma for Treatment of COVID-19CompletedPhase 2/3Joakim DillnerNCT04649879Written as SARS-CoV-2 convalescent plasma
- Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19)CompletedPhase 1/2Joakim DillnerNCT04390178Written as SARS-CoV-2 convalescent plasma